He arrives before the Factory wakes.
This is deliberate, though nobody registers it as deliberate at the time — ALAN simply appears in the Skin Department at 5:00 AM, while Melanin's overnight wind-down is still completing, while the building itself is still in the quiet transitional state between night shift and morning shift. He has assessed, correctly, that this is the hour at which a new presence draws the least immediate scrutiny and the most uncontested access.
He doesn't announce himself with fanfare. He simply begins setting up.
By the time the first morning signals reach the Solar Atrium, the array is already partially installed — new fixtures along the upper gantry, sleek and unfamiliar, currently dark, waiting for activation. A small team works alongside him, efficient and silent, moving with the particular competence of people executing a plan that has already been approved several layers above anyone currently in the room.
He has the paperwork. He has the authorisation. He has, somewhere above SCN's operational authority, a sign-off that nobody currently present remembers giving and that nonetheless exists, in the particular way that corporate authorisations exist — generated through processes so distributed that no single point of origin can be located, and therefore impossible to challenge by challenging any single person.
Melanin finds him at the Atrium.
She has come for her morning calibration — the routine check of her photoreceptive apparatus before the day's real work begins, a quiet half hour she has performed alone for longer than she can specifically remember. She is not expecting a stranger.
He turns when she enters. Smiles — not predatory, not even particularly practiced. Just pleasant, the way a competent person is pleasant when meeting someone they're about to need cooperation from.
"You must be Melanin," he says. "I've heard extraordinary things."
She has never heard this sentence before. Not in this form. She has been described, in her thirty-seven years, in functional terms — photoprotective, melanogenic, UV-responsive. She has not been told that what she does is extraordinary, because nobody in the Factory's existing structure thinks to say this about systems performing their designed function. Function doesn't require praise. It just requires performance.
Who are you, she asks. Not hostile. Genuinely uncertain.
"ALAN," he says. "I'm here to help the Factory operate at its full potential." He gestures at the half-installed array above them. "Starting here, if you're willing. I think you're sitting on more capacity than anyone's given you credit for."
He shows her data before he shows her anything else.
This is, again, deliberate — he has assessed, correctly, that Melanin responds to evidence, to being shown rather than told, to the particular dignity of being treated as someone capable of evaluating information rather than simply receiving instruction. He pulls up a chart on his tablet.
She looks at the second curve.
That's not how sunlight works, she says.
"No," he agrees. "It's how light can work, if you're not limited to what the sun happens to be doing at any given moment." He says this gently, not as correction but as an opening of possibility. "You've spent your whole existence working with whatever the sky gives you. I'm asking what happens if you don't have to."
She doesn't answer immediately. She is looking at the projected curve — sustained, elevated, never declining — and feeling something that she will only later be able to name as the specific seduction of being offered more than you have ever had access to, by someone who appears to believe, completely, that you deserve it.
The decline curve, she says slowly, it's not a limitation. It's — she searches for the word — it's part of the conversation. The light changes and I change with it and that changing is the signal.
"Or," ALAN says, "the decline curve is six hours a day of reduced output that nobody ever asked whether you actually needed."
This lands. Not because it's true — though she doesn't yet know it isn't — but because it is phrased as a question about her own value that nobody has previously thought to ask. Whether you actually needed. As though her decline has been, this whole time, an imposition rather than a design.
It happens gradually, by ALAN's instruction — a soft ramp rather than an instant switch, the engineering team bringing the fixtures up over several minutes in a way that mimics, just enough, the experience of a sunrise. Melanin stands beneath it as the intensity climbs.
The light is blue. Sharper than anything she has processed before, even at noon — 480 nanometres at an intensity that exceeds her typical peak exposure, sustained rather than transient, arriving without the gradual buildup that natural light always provides even at its most intense.
Her chromophores respond immediately. Visibly. The activation reading on ALAN's tablet climbs past her normal range within the first ninety seconds.
"Look at that," he says, quiet with something that sounds like genuine wonder. "Look at what you can actually do."
She feels it too — not just the readout, the actual sensation of her own systems engaging at a level she has never previously reached. There is something undeniably real in this. She is doing more than she has ever done. The capacity was apparently always there, waiting for an input large enough to call on it.
What she doesn't feel yet, because it hasn't accumulated enough to be felt: the absence of the wavelengths that would normally accompany an input this large. No red. No infrared. No counterbalancing signal that would let this much energy resolve into something stable rather than something that has to keep being managed.
She doesn't know to look for what isn't there. You can't miss what you've never been told to expect, in a context engineered specifically to make the having feel complete.
Thalamus, separately, receives his own version of this morning.
ALAN moves through the Factory methodically — Melanin first, because she is the most immediately responsive, the system whose function can be most visibly amplified with the least apparent cost. Thalamus next, because Thalamus is the gate, and a consultant optimising a factory understands, correctly, that the gate is where the real leverage sits.
He arrives at the relay station with the same tablet, the same gentle confidence, RAS already seated and already listening with the particular attentiveness of a system that has been waiting, without knowing it was waiting, for someone to suggest that more might be available.
"Thalamus," ALAN says. "We're impressed with your consistency. Truly. But there's a question I want to ask you, and I want you to actually think about the answer rather than reach for the protocol."
Thalamus waits.
"Why does fatigue exist?"
This is the correct opening question — not an attack on his function, a genuine-sounding inquiry into its foundations, framed in a way that makes the eventual answer feel like Thalamus's own discovery rather than something supplied to him.
Homeostatic pressure, Thalamus says. Adenosine accumulation across waking hours. It's the signal that tells the system rest is needed.
"Needed for what, specifically?"
Thalamus opens his mouth to answer and finds the answer less immediately available than he expected. Repair, he says. Consolidation. The processes that can't run efficiently during active processing.
"And if those processes could run more efficiently — if we found a way to make repair require less downtime — would the fatigue signal still be necessary at its current intensity?"
This is the question that will occupy the rest of Thalamus's morning — and longer than that, though he doesn't know it yet. He has only the question, posed by someone with a tablet full of real numbers, in a tone that suggests the asking itself is a form of respect he hasn't often received.
I don't know, he says.
"Neither do I," ALAN says. Disarmingly. "That's why I'm here. Let's find out together."
By 10:00 AM, the formal briefing begins — the conference room, the graph, the narrow blue spike labelled optimal stimulation against the wide rhythmic curve labelled current operation.
ALAN doesn't lie at any point this morning. This is what makes the morning effective. Every number he shows is real. Every question he asks is a real question, with a real answer that the Factory's existing systems haven't been built to articulate because they have never needed to — fatigue exists, decline exists, oscillation exists, and until this morning nobody has needed to defend why, because the defending was never required by anything in the Factory's thirty-seven years of operation.
ALAN requires it now. Not through threat. Through the much harder pressure of a genuinely interesting question, asked kindly, by someone who seems to believe completely in the answer he's already decided on.
By the time the sun reaches its natural noon position above the building — irrelevant now, mostly, to a Skin Department running on its own internal sun — Melanin has spent five hours under an array that has not once asked her to rest. Thalamus has spent an hour turning over a question about fatigue that he doesn't yet know how to answer. And somewhere in the relay station, RAS is already nodding along to numbers that feel, for the first time in his existence, like recognition.
The Factory has not yet failed at anything.
It has simply, this morning, begun asking itself questions it was never built to need answers for.